Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Multiscale mathematical modeling vs. the generalized transfer function approach for aortic pressure estimation: a comparison with invasive data.

Guala A, Tosello F, Leone D, Sabia L, D'Ascenzo F, Moretti C, Bollati M, Veglio F, Ridolfi L, Milan A.

Hypertens Res. 2018 Dec 10. doi: 10.1038/s41440-018-0159-5. [Epub ahead of print]

PMID:
30531842
2.

Cardiac magnetic resonance for ischaemia and viability detection. Guiding patient selection to revascularization in coronary chronic total occlusions: The CARISMA_CTO study design.

Pica S, Di Giovine G, Bollati M, Testa L, Bedogni F, Camporeale A, Pontone G, Andreini D, Monti L, Gasparini G, Grancini L, Secco GG, Maestroni A, Ambrogi F, Milani V, Lombardi M.

Int J Cardiol. 2018 Dec 1;272:356-362. doi: 10.1016/j.ijcard.2018.08.061. Epub 2018 Aug 22.

PMID:
30173921
3.

Patient selection and percutaneous technique of unprotected left main revascularization.

Testa L, Latib A, Bollati M, Bedogni F.

Catheter Cardiovasc Interv. 2018 Oct 1;92(4):637-643. doi: 10.1002/ccd.27528. Epub 2018 Mar 9.

PMID:
29521440
4.

Identification of a small molecule that compromises the structural integrity of viroplasms and rotavirus double-layered particles.

Eichwald C, De Lorenzo G, Schraner EM, Papa G, Bollati M, Swuec P, de Rosa M, Milani M, Mastrangelo E, Ackermann M, Burrone OR, Arnoldi F.

J Virol. 2017 Nov 15. pii: JVI.01943-17. doi: 10.1128/JVI.01943-17. [Epub ahead of print]

5.

APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot study.

Leonardi S, Marino M, Crimi G, Maiorana F, Rizzotti D, Lettieri C, Bettari L, Zuccari M, Sganzerla P, Tresoldi S, Adamo M, Ghiringhelli S, Sponzilli C, Pasquetto G, Pavei A, Pedon L, Bassan L, Bollati M, Camisasca P, Trabattoni D, Brancati M, Poli A, Panciroli C, Lettino M, Tarelli G, Tarantini G, De Luca L, Varbella F, Musumeci G, De Servi S.

BMJ Open. 2017 Sep 5;7(9):e016909. doi: 10.1136/bmjopen-2017-016909.

6.

Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials.

Testa L, Latib A, Bollati M, Antonio Montone R, Colombo A, Crea F, Bedogni F.

PLoS One. 2017 Jun 28;12(6):e0179060. doi: 10.1371/journal.pone.0179060. eCollection 2017. Review.

7.

Rationale and design of a multicenter, international and collaborative Coronary Artery Aneurysm Registry (CAAR).

Núñez-Gil IJ, Nombela-Franco L, Bagur R, Bollati M, Cerrato E, Alfonso E, Liebetrau C, De la Torre Hernandez JM, Camacho B, Mila R, Amat-Santos IJ, Alfonso F, Rodríguez-Olivares R, Camacho Freire SJ, Lozano Í, Jiménez Díaz VA, Piraino D, Latini RA, Feltes G, Linares JA, Mancone M, Ielasi A, Sánchez-Grande Flecha A, Fernández Cisnal A, Ugo F, Jiménez Mazuecos JM, Omedè P, Pavani M, Villablanca PA, Louka BF, Fernández-Ortiz A; CAAR Investigators.

Clin Cardiol. 2017 Aug;40(8):580-585. doi: 10.1002/clc.22705. Epub 2017 Mar 24.

8.

Feasibility of carotid artery stenting with double cerebral embolic protection in high-risk patients.

Varbella F, Gagnor A, Rolfo C, Cerrato E, Bollati M, Giay Pron P, Hartwig M, Palacio Restrepo S, Reggiani M, Amarù S, Luda di Cortemiglia E, Tomassini F.

Catheter Cardiovasc Interv. 2016 Feb 15;87(3):432-7. doi: 10.1002/ccd.26218. Epub 2015 Sep 10.

PMID:
26354364
9.

[Position paper on the theoretical basis, practical application and health economic evaluation of the functional assessment of coronary lesions endorsed by the Italian Society of Invasive Cardiology (SICI-GISE)].

Bedogni F, Indolfi C, Ribichini F, Verna E, Leone AM, Polimeni A, Bollati M, Biondi-Zoccai G, Testa L, Berti S; Italian Society of Invasive Cardiology (SICI-GISE).

G Ital Cardiol (Rome). 2015 Feb;16(2):116-28. doi: 10.1714/1798.19590. Italian.

PMID:
25805097
10.

Crystal structure of LptH, the periplasmic component of the lipopolysaccharide transport machinery from Pseudomonas aeruginosa.

Bollati M, Villa R, Gourlay LJ, Benedet M, Dehò G, Polissi A, Barbiroli A, Martorana AM, Sperandeo P, Bolognesi M, Nardini M.

FEBS J. 2015 May;282(10):1980-97. doi: 10.1111/febs.13254. Epub 2015 Mar 20.

11.

Setting up a multidisciplinary program of carotid artery stenting in a community hospital: initial experience of 277 patients.

Varbella F, Gagnor A, Rolfo C, Cerrato E, Bollati M, Gambino A, Pron PG, Hartwig M, Reggiani M, Amarù S, di Cortemiglia EL, Tomassini F.

Int J Cardiol. 2015 Jan 20;179:17-9. doi: 10.1016/j.ijcard.2014.10.070. Epub 2014 Oct 22. No abstract available.

PMID:
25464396
12.

Appraising failure of surgical and percutaneous revascularization: long term outcomes from an observational registry.

D'Ascenzo F, Bollati M, Quadri G, Gonella A, Di Cuia M, De Simone V, Colaci C, Reitano C, Vagnarelli M, Biondi Zoccai G, Moretti C, Sciuto F, Omedè P, Sheiban I, Gaita F.

Minerva Cardioangiol. 2013 Dec;61(6):675-81.

PMID:
24253459
13.

Impact of thrombus aspiration during primary percutaneous coronary intervention in cardiogenic shock complicating ST-segment elevation myocardial infarction.

Tomassini F, Gagnor A, Montali N, Gambino A, Bollati M, Infantino V, Rigattieri S, Varbella F.

Cardiovasc Revasc Med. 2013 Nov-Dec;14(6):307-10. doi: 10.1016/j.carrev.2013.08.006. Epub 2013 Sep 24.

PMID:
24075314
14.

Is percutaneous coronary intervention of unprotected left main coronary artery via transradial approach feasible for skilled transfemoral operators? Initial experience in an unselected population.

Tomassini F, Gagnor A, Montali N, Gambino A, Bollati M, Infantino V, Tizzani E, Varbella F.

Cardiovasc Revasc Med. 2013 Jul-Aug;14(4):193-6. doi: 10.1016/j.carrev.2013.04.007. Epub 2013 Jun 13.

PMID:
23768506
15.

Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies.

Presutti DG, D'Ascenzo F, Omedè P, Biondi-Zoccai G, Moretti C, Bollati M, Sciuto F, Lee MS, Moreno R, Bikkina M, Di Cuia M, Resmini C, Gaita F, Sheiban I.

J Cardiovasc Med (Hagerstown). 2013 Nov;14(11):773-9. doi: 10.2459/JCM.0b013e3283619410. Review.

PMID:
23756410
16.

Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention.

Quadri G, D'ascenzo F, Bollati M, Moretti C, Omedé P, Sciuto F, Gonella A, Pullara A, Longo G, Cerrato E, Colombo F, Presutti DG, Colaci C, De Simone V, Di Cuia M, Giusto F, Reitano C, Zoccai GB, Sheiban I, Gaita F.

Acta Cardiol. 2013 Apr;68(2):151-60.

PMID:
23705557
17.

Incidence and very long- term outcomes of stent thrombosis after bare-metal or drug-eluting stent implantation: a retrospective analysis.

Pullara A, Longo G, Gonella A, D'Ascenzo F, Biondi Zoccai G, Moretti C, Sciuto F, Omedè PL, Bollati M, Gaita F, Sheiban I.

Minerva Cardioangiol. 2013 Feb;61(1):1-9.

PMID:
23381375
18.

Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.

Resmini C, Di Cuia M, Ballocca F, D'Ascenzo F, Bollati M, Moretti C, Omedè PL, Sciuto F, Gaita F, Sheiban I.

Minerva Cardioangiol. 2012 Dec;60(6):573-80.

PMID:
23147435
19.

Very long-term outcome of peripheral arterial disease in patients undergoing percutaneous coronary revascularization: a retrospective analysis.

Pullara A, D'Ascenzo F, Gonella A, Moretti C, Sciuto F, Omedè PL, Bollati M, Biondi Zoccai G, Gaita F, Sheiban I.

Minerva Cardioangiol. 2012 Dec;60(6):553-60.

PMID:
23147433
20.

Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.

Narula N, Favalli V, Tarantino P, Grasso M, Pilotto A, Bellazzi R, Serio A, Gambarin FI, Charron P, Meder B, Pinto Y, Elliott PM, Mogensen J, Bolognesi M, Bollati M, Arbustini E.

J Am Coll Cardiol. 2012 Nov 6;60(19):1916-20. doi: 10.1016/j.jacc.2012.05.059. Epub 2012 Oct 10.

21.

Use and misuse of multivariable approaches in interventional cardiology studies on drug-eluting stents: a systematic review.

D'Ascenzo F, Cavallero E, Biondi-Zoccai G, Moretti C, Omedè P, Bollati M, Castagno D, Modena MG, Gaita F, Sheiban I.

J Interv Cardiol. 2012 Dec;25(6):611-21. doi: 10.1111/j.1540-8183.2012.00753.x. Epub 2012 Aug 13. Review.

PMID:
22882654
22.

30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study.

D'Ascenzo F, Moretti C, Salizzoni S, Bollati M, D'Amico M, Ballocca F, Giordana F, Barbanti M, Ussia GP, Brambilla N, Bedogni F, Biondi Zoccai G, Tamburino C, Gaita F, Sheiban I.

Int J Cardiol. 2013 Aug 20;167(4):1514-8. doi: 10.1016/j.ijcard.2012.04.161. Epub 2012 Jun 20.

PMID:
22726400
23.

Changing of SYNTAX score performing fractional flow reserve in multivessel coronary artery disease.

Novara M, D'Ascenzo F, Gonella A, Bollati M, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Sheiban I, Gaita F.

J Cardiovasc Med (Hagerstown). 2012 Jun;13(6):368-75. doi: 10.2459/JCM.0b013e3283536adc.

PMID:
22499002
24.

Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses.

D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernandez JM, ten Berg JM, Brodie BR, Urban P, Jensen LO, Sardi G, Waksman R, Lasala JM, Schulz S, Stone GW, Airoldi F, Colombo A, Lemesle G, Applegate RJ, Buonamici P, Kirtane AJ, Undas A, Sheiban I, Gaita F, Sangiorgi G, Modena MG, Frati G, Biondi-Zoccai G.

Int J Cardiol. 2013 Jul 31;167(2):575-84. doi: 10.1016/j.ijcard.2012.01.080. Epub 2012 Feb 22.

PMID:
22360945
25.

Structures of the lamin A/C R335W and E347K mutants: implications for dilated cardiolaminopathies.

Bollati M, Barbiroli A, Favalli V, Arbustini E, Charron P, Bolognesi M.

Biochem Biophys Res Commun. 2012 Feb 10;418(2):217-21. doi: 10.1016/j.bbrc.2011.12.136. Epub 2012 Jan 10.

26.

TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients.

D'Ascenzo F, Biondi-Zoccai G, Moretti C, Bollati M, Omedè P, Sciuto F, Presutti DG, Modena MG, Gasparini M, Reed MJ, Sheiban I, Gaita F.

Contemp Clin Trials. 2012 May;33(3):507-14. doi: 10.1016/j.cct.2012.01.001. Epub 2012 Jan 11. Review.

PMID:
22265976
27.

Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy.

D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Bollati M, Modena MG, Gaita F, Sheiban I.

Eur Heart J. 2012 Apr;33(7):875-80. doi: 10.1093/eurheartj/ehr456. Epub 2011 Dec 20. Review.

28.

Dual oral antiplatelet therapy and unplanned surgery: possible role for intravenous platelet glycoprotein receptor inhibitors.

Bollati M, Giraudi E, Moretti C, Millesimo G, Sciuto F, Omedè P, Biondi Zoccai G, Sheiban I.

J Cardiovasc Med (Hagerstown). 2011 Sep;12(9):673-4. doi: 10.2459/JCM.0b013e328339d89a. No abstract available.

PMID:
21796059
29.

Antiplatelet combinations for prevention of atherothrombotic events.

Bollati M, Gaita F, Anselmino M.

Vasc Health Risk Manag. 2011 Jan 12;7:23-30. doi: 10.2147/VHRM.S12271. Review.

30.

Percutaneous drug-eluting stent implantation in diabetic patients: short and long term outcomes from an observational study.

Longo G, Gonella A, D'Ascenzo F, Quadri G, Bollati M, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Gaita F, Sheiban I.

Minerva Cardioangiol. 2011 Feb;59(1):1-7.

PMID:
21285926
31.

Postpartum valve thrombosis: a happy ending thriller.

Bollati M, Moretti C, Sciuto F, Omedè P, Marra WG, Morello M, Grimaldi R, Rabbia C, Zoccai GB, Sheiban I.

J Cardiovasc Med (Hagerstown). 2015 Jan;16 Suppl 1:S49-50. doi: 10.2459/JCM.0b013e328341033d.

PMID:
21157367
32.

Takotsubo cardiomyopathy as a complication of pacemaker implantation.

Golzio PG, Anselmino M, Presutti D, Cerrato E, Bollati M, Gaita F.

J Cardiovasc Med (Hagerstown). 2011 Oct;12(10):754-60. doi: 10.2459/JCM.0b013e3283403563. No abstract available.

PMID:
21135591
33.

Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.

Cabrera M, Lavaggi ML, Croce F, Celano L, Thomson L, Fernández M, Pintos C, Raymondo S, Bollati M, Monge A, López de Ceráin A, Piro OE, Cerecetto H, González M.

Bioorg Med Chem. 2010 Jul 15;18(14):5391-9. doi: 10.1016/j.bmc.2010.05.033. Epub 2010 May 20.

PMID:
20639112
34.

Short and long-term outcomes of percutaneous revascularization in patients with prior coronary artery bypass graft.

D'Ascenzo F, Gonella A, Longo G, Pullara A, Bollati M, Vagnarelli M, Biondi Zoccai G, Moretti C, Sciuto F, Omedè P, Trevi GP, Sheiban I.

Minerva Cardioangiol. 2010 Jun;58(3):291-9.

PMID:
20485236
35.

The future of new aortic valve replacement approaches.

Bollati M, Tizzani E, Moretti C, Sciuto F, Omede P, Zoccai GB, Trevi GP, Abbate A, Sheiban I.

Future Cardiol. 2010 May;6(3):351-60. doi: 10.2217/fca.10.14. Review.

PMID:
20462341
36.

Impact of multivessel coronary disease on long-term outcome after percutaneous recanalization of coronary chronic total occlusions.

La Spina C, Biondi-Zoccai G, Moretti C, Sciuto F, Omedè P, Bollati M, Siliquini R, Chiadò S, Trevi GP, Sheiban I.

Minerva Cardioangiol. 2010 Apr;58(2):159-65.

PMID:
20440245
37.

Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function.

Bollati M, Gerasimou A, Sillano D, Biondi-Zoccai G, Garrone P, Moretti C, Sciuto F, Omedé P, Trevi GP, Sheiban I.

Catheter Cardiovasc Interv. 2010 Mar 1;75(4):586-93. doi: 10.1002/ccd.22243.

PMID:
20088012
38.

Structure and functionality in flavivirus NS-proteins: perspectives for drug design.

Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould EA, Grard G, Grimes JM, Hilgenfeld R, Jansson AM, Malet H, Mancini EJ, Mastrangelo E, Mattevi A, Milani M, Moureau G, Neyts J, Owens RJ, Ren J, Selisko B, Speroni S, Steuber H, Stuart DI, Unge T, Bolognesi M.

Antiviral Res. 2010 Aug;87(2):125-48. doi: 10.1016/j.antiviral.2009.11.009. Epub 2009 Nov 27. Review.

39.

Anomalous origin of the left anterior descending artery from the right coronary artery.

Garrone P, Bollati M, Moretti C.

Minerva Cardioangiol. 2009 Oct;57(5):683-4. No abstract available.

PMID:
19838157
40.

Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition.

Milani M, Mastrangelo E, Bollati M, Selisko B, Decroly E, Bouvet M, Canard B, Bolognesi M.

Antiviral Res. 2009 Jul;83(1):28-34. doi: 10.1016/j.antiviral.2009.03.001. Epub 2009 Mar 14.

PMID:
19501254
41.

Buddy balloon to deliver a percutaneous aortic valve device: a percutaneous shoehorn?

Sheiban I, Infantino V, Bollati M.

Catheter Cardiovasc Interv. 2009 Nov 1;74(5):805-7. doi: 10.1002/ccd.22118.

PMID:
19496133
42.

Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions.

Sheiban I, Infantino VA, Colombo F, Bollati M, Omedè P, Moretti C, Sciuto F, Siliquini R, Chiadò S, Trevi GP, Biondi-Zoccai G.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):313-20. doi: 10.1002/ccd.22023.

PMID:
19496110
43.

The SARS-unique domain (SUD) of SARS coronavirus contains two macrodomains that bind G-quadruplexes.

Tan J, Vonrhein C, Smart OS, Bricogne G, Bollati M, Kusov Y, Hansen G, Mesters JR, Schmidt CL, Hilgenfeld R.

PLoS Pathog. 2009 May;5(5):e1000428. doi: 10.1371/journal.ppat.1000428. Epub 2009 May 15.

44.

Crystal structure of a methyltransferase from a no-known-vector Flavivirus.

Bollati M, Milani M, Mastrangelo E, de Lamballerie X, Canard B, Bolognesi M.

Biochem Biophys Res Commun. 2009 Apr 24;382(1):200-4. doi: 10.1016/j.bbrc.2009.03.008. Epub 2009 Mar 9.

PMID:
19275894
45.

Percutaneous aortic valve replacement in two cases at high surgical risk: procedural details and implications for patient selection.

Bollati M, Moretti C, Omedè P, Sciuto F, Grosso Marra W, Palumbo L, Biondi-Zoccai G, Sheiban I.

Minerva Cardioangiol. 2009 Feb;57(1):131-6.

PMID:
19202524
46.

Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease.

Sheiban I, Gerasimou A, Bollati M, Biondi-Zoccai G, Sciuto F, Omedé P, Sillano D, Trevi GP, Moretti C.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):25-31. doi: 10.1002/ccd.21759.

PMID:
19089932
47.

Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus.

Bollati M, Milani M, Mastrangelo E, Ricagno S, Tedeschi G, Nonnis S, Decroly E, Selisko B, de Lamballerie X, Coutard B, Canard B, Bolognesi M.

J Mol Biol. 2009 Jan 9;385(1):140-52. doi: 10.1016/j.jmb.2008.10.028. Epub 2008 Oct 19.

PMID:
18976670
48.

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V).

Sheiban I, Villata G, Bollati M, Sillano D, Lotrionte M, Biondi-Zoccai G.

Vasc Health Risk Manag. 2008;4(1):31-8. Review.

49.

Revisiting the role of percutaneous revascularization versus medical therapy for later infarct-related artery occlusion (letter of comment on Ioannidis and Katritsis. Am Heart J. 2007;154:1065-71).

Appleton D, Abbate A, Biondi-Zoccai GG, Delcré S, Bollati M, Sheiban I, Agostoni P.

Am Heart J. 2008 Apr;155(4):e41; author reply e43. doi: 10.1016/j.ahj.2007.12.029. Epub 2008 Feb 21. No abstract available.

PMID:
18371460
50.

Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years?

Bollati M, Biondi-Zoccai GG, Gambino A, Lombardi P, Sheiban I.

J Cardiovasc Med (Hagerstown). 2008 Apr;9(4):403-5. doi: 10.2459/JCM.0b013e32827853d6.

PMID:
18334896

Supplemental Content

Loading ...
Support Center